Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

OATP-C Inhibitors

OATP-C inhibitors, also known as organic anion transporting polypeptide-C inhibitors, belong to a specific class of chemical compounds that have garnered significant attention in the field of pharmacology and drug development. These inhibitors are characterized by their ability to interfere with the function of OATP-C transporters, which are membrane proteins found in various tissues, particularly in the liver and the intestine. OATP-C transporters play a crucial role in the transport of a diverse range of endogenous and exogenous compounds, including drugs and metabolites, across cell membranes. By inhibiting the activity of these transporters, OATP-C inhibitors can modulate the uptake and disposition of various substrates, ultimately impacting their pharmacokinetics and pharmacodynamics. The development and study of OATP-C inhibitors have gained significance due to their implications in drug-drug interactions. These inhibitors are particularly relevant in the context of drug development and safety, as they can influence the absorption, distribution, and elimination of co-administered drugs by altering their cellular uptake. Researchers focus on understanding the structural and mechanistic aspects of OATP-C inhibition to identify drug candidates. Ultimately, a comprehensive understanding of OATP-C inhibitors' effects on the transport of various compounds can contribute to more informed drug design and administration.

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Gemfibrozil

25812-30-0sc-204764
sc-204764A
5 g
25 g
$66.00
$267.00
2
(2)

Gemfibrozil could potentially inhibit OATP-C by activating peroxisome proliferator-activated receptor alpha (PPARα), which may influence SLCO1B1 expression.

Ginkgolide B

15291-77-7sc-201037B
sc-201037
sc-201037C
sc-201037A
5 mg
10 mg
25 mg
50 mg
$46.00
$64.00
$114.00
$201.00
8
(1)

Ginkgolide B, a component of Ginkgo biloba, may affect OATP-C expression by modulating transporter-specific regulatory pathways.